Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J E, Levinson"'
Publikováno v:
Clinical and experimental rheumatology. 24(3)
To correlate disease course and complications in children with juvenile dermatomyositis (JDM) and polymyositis (JPM) with specific features of muscle pathology on biopsy.This is a retrospective cohort analysis of 59 children diagnosed with JDM or JPM
Autor:
D J, Lovell, C B, Lindsley, R M, Rennebohm, S H, Ballinger, S L, Bowyer, E H, Giannini, J E, Hicks, J E, Levinson, R, Mier, L M, Pachman, M H, Passo, M D, Perez, A M, Reed, K N, Schikler, M, Smith, L S, Zemel, L G, Rider
Publikováno v:
Arthritis and rheumatism. 42(10)
To develop, validate, and determine the measurement characteristics of a quantitative tool for assessing the severity of muscle involvement in children with idiopathic inflammatory myopathies.The Childhood Myositis Assessment Scale (CMAS) was develop
Autor:
N, Ruperto, J E, Levinson, A, Ravelli, E S, Shear, B, Link Tague, K, Murray, A, Martini, E H, Giannini
Publikováno v:
The Journal of rheumatology. 24(5)
To assess the long-term health outcomes and quality of life of patients with juvenile rheumatoid arthritis (JRA) using health and functional assessment questionnaires in 2 populations, one from the USA and one from Italy.Patient eligibility criteria:
Autor:
K J, Murray, W, Szer, A A, Grom, P, Donnelly, J E, Levinson, E H, Giannini, D N, Glass, I S, Szer
Publikováno v:
The Journal of rheumatology. 24(3)
To study the frequency of autoantibodies to the 45 kDa DEK nuclear antigen, a putative oncoprotein, in a sample of patients with juvenile rheumatoid arthritis (JRA), and to make correlations with disease subtype and complications such as iridocycliti
Publikováno v:
The Journal of rheumatology. 23(12)
To determine if the germ line gene VH4-34 (VH4.21) encodes the antimonophosphoryl lipid A (MPL) polyspecific antibodies found in oligoarticular arthritis of childhood.Sera from a range of rheumatic diseases of childhood were assayed for VH4-34 derive
Autor:
J E, Levinson, C A, Wallace
Publikováno v:
The Journal of rheumatology. Supplement. 33
The suggestion is heard, with increasing frequency, that the therapeutic pyramid be dismantled and that medical management be reordered to treat juvenile rheumatoid arthritis as early and as decisively as possible to induce prompt remission of diseas
Autor:
C A, Wallace, J E, Levinson
Publikováno v:
Rheumatic diseases clinics of North America. 17(4)
There has been much discontent with the hazards and the uncertain responses of patients with juvenile rheumatoid arthritis (JRA) to time-honored modalities of management. The treatment of JRA is often thought of as a pyramid with the base formed by n
Autor:
E H, Giannini, C N, Malagon, C, Van Kerckhove, J, Taylor, D J, Lovell, J E, Levinson, M H, Passo, J, Ginsberg, M J, Burke, D N, Glass
Publikováno v:
The Journal of rheumatology. 18(9)
The risk of iridocyclitis in children with early onset pauciarticular juvenile rheumatoid arthritis (EOPA-JRA) has been shown to be associated with certain HLA haplotypes. Our report contains an actuarial analysis, using one-year intervals, of 161 su
Publikováno v:
Pediatrics. 86(6)
A juvenile rheumatoid arthritis-like arthropathy has previously been documented in 12 patients with Down syndrome. An additional 9 patients are described and the literature is reviewed. It is unknown whether these patients have juvenile rheumatoid ar
Autor:
Walter P. Maksymowych, Lorie Luyrink, E Choi, Martin G. Larson, David N. Glass, C. Van Kerckhove, Maruja S. Elma, J. E. Levinson
Publikováno v:
Immunogenetics. 32(5)